Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRZQC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,361
Award facts
- Contract value 100% obligated
- $40,361.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $40,361.19. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively evaluated. The contract represents a continuation of the company's pharmaceutical supply role supporting federal medical procurement needs, with performance to be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and eosinophilic esophagitis, addressing specialized pharmaceutical requirements within the federal healthcare supply chain.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The delivery order demonstrates the company's established capacity as a critical pharmaceutical distributor within the federal medical supply chain and reflects the Defense Logistics Agency's reliance on AmerisourceBergen for specialized pharmaceutical products supporting military and federal health services.
Quick answers
Who was awarded contract SPE2DB25FRZQC?
SPE2DB25FRZQC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 24, 2025.
How much is contract SPE2DB25FRZQC worth?
The government has obligated $40,361 on SPE2DB25FRZQC.
Is contract SPE2DB25FRZQC an order under another contract?
Yes. SPE2DB25FRZQC is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRZQC competed?
The extent of competition for SPE2DB25FRZQC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award